Relicensing Clause Samples
Relicensing. Any contributor may relicense the project as a whole by granting a sublicense under new terms meeting any license criteria in effect at the time within thirty calendar days of securing majority approval. When soliciting votes for relicensing, a contributor must circulate: identification of the contributor proposing to relicense the project an exact copy of the new license terms an exact copy of all the terms of any agreement that has, will, or could compensate the contributor for proposing or securing approval of the relicensing License Criteria The first two contributors must agree on any criteria for terms on which the project can be relicensed. They must publish a dated statement of those criteria, or a dated statement that there are no criteria, together with the terms of this agreement, where potential contributors can find and read them. No contributor can relicense the project onto new terms that fail to meet the license criteria. Any contributor may change the license criteria by securing supermajority approval in favor of the change. Communications Equal Information Each contributor is entitled to receive each message sent to any other contributor under these terms. Circulating Messages To circulate a message under these terms, a contributor must send the message in the English language to each other contributor, retrying as necessary. Circulating Notices Any contributor who receives a notice under the terms of a relicensing must circulate that notice, retrying as necessary.
Relicensing. Any contributor may relicense the project as a whole by granting a sublicense under new terms meeting any license criteria in effect at the time within thirty calendar days of securing majority approval. When soliciting votes for relicensing, a contributor must circulate:
Relicensing. VAR shall market, sell and license to institutions, companies, corporations and other entities ("Corporate/Institutional Accounts") access to HealthGate Series of Products (as defined in Section 2.1, below) pursuant to the terms of this Agreement. With the exception of the defined "VAR Territory", as defined in Schedule D, VAR shall contact HealthGate and register each prospect in advance of licensing a HealthGate Series of Products to
Relicensing. If the License Agreement has been terminated (in its entirety or with respect to certain Regions or Licensed Products), then (i) Subscriber shall have the right to consult and cooperate with Issuer to identify and pursue one or more alternative licensing arrangements with respect to the terminated Region(s) or Licensed Product(s), as applicable, in the ▇▇▇▇▇ Territory (i.e., grants of new licenses or sublicenses to any Genfit Technology, and any ▇▇▇▇▇ Licensed Patent Rights or ▇▇▇▇▇ Licensed Know-How licensed to Issuer) through one or more third parties reasonably satisfactory to Subscriber and Issuer, on commercially reasonable terms, as determined by the Issuer and Subscriber acting reasonably, which right Subscriber may exercise by written notice to Issuer, and (ii) Issuer shall use commercially reasonable efforts to negotiate and enter into agreements as are reasonably necessary in furtherance thereof. All reasonable out of pocket costs and expenses (including attorneys’ fees and expenses) incurred by Subscriber pursuant to this Section 5.7(c) shall be borne by Subscriber. All reasonable out of pocket costs and expenses (including attorneys’ fees and expenses) incurred by Issuer pursuant to this Section 5.7(c) and not paid for out of the closing proceeds, if any, of such new agreements shall be borne by Issuer. If Issuer shall enter into any new agreement(s) pursuant to this Section 5.7(c), then, for no additional consideration from Subscriber, (x) Subscriber shall be entitled to the same rights under such new agreement(s), mutatis mutandis, as those provided for under the License Agreement (excluding any payments owed by Issuer to Licensee pursuant to Section 13.6(c)(ii) of the License Agreement) pursuant to the Transaction Documents, (y) such new agreement(s) shall provide that all payments thereunder corresponding to the Receivables shall be assigned to Fiduciaire to be held in trust for the benefit of Subscriber and Issuer, according to their respective interests in the Fiduciary Assets (which payments, for the avoidance of doubt, will promptly, and in any event within [***] Business Days, be paid by the Fiduciaire to Subscriber as additional repayment of the Bonds under the Terms and Conditions of the Bonds until the end of the Royalty Period), and (z) Subscriber, Fiduciaire and Issuer shall modify the terms of this Support Agreement and the other Transaction Documents to reflect such new agreement and to reflect, as closely as possible, with resp...
Relicensing. Assignee shall promptly apply for relicensing ----------- of the Leased Premises as a skilled nursing facility in the name of the Assignee.